The microtubule-associated protein AtMAP65-1 from Arabidopsis thaliana dimerizes and forms 25 nm cross-bridges between microtubules, but the exact mechanism is unknown. Here, we used the predicted three-dimensional structure of AtMAP65-1 as a basis for analyzing the actual cross-bridging in detail. Fold-recognition predicts that AtMAP65-1 contains four coiled-coil domains and a flexible extended loop. The length of these coiled-coil domains is about 25 nm, suggesting that one molecule could span the gap, hence forming an antiparallel overlapping dimer instead of an end-to-end dimer. We then tested this model by using truncations of AtMAP65-1. EDC {[3-(dimethylamino) propyl] carbodiimide} cross-linking analysis indicated that the N-terminus of the rod domain of AtMAP65-1 (amino acids 1-339) binds to the C-terminus of the rod domain (amino acids 340-494) and also participates in connecting the two antiparallel proteins in the cross-bridge. Nevertheless, microtubules can still form bundles in the presence of AtMAP65-1 340-587 (amino acids 340-587) or AtMAP65-1 1-494 (amino acids 1-494). Comparing the cold stability of microtubule bundles induced by full-length AtMAP65-1 with that of AtMAP65-1 340-587 or AtMAP65-1 1-494, we conclude that AtMAP65-1 495-587 acts as a flexible extended loop, playing a crucial role in binding to and stabilizing microtubules in the AtMAP65-1 cross-bridge.
Introduction
Microtubule-associated proteins (MAPs) help to regulate the organizations of plant microtubules (Lloyd et al. 2001 , Sedbrook 2004 , Hamada 2007 . One of the best-studied is MAP65/anaphase spindle elongation 1 (Ase1)/PROTEIN REGULATING CYTOKINESIS 1 (PRC1), which forms a family of evolutionarily conserved MAPs found in probably all groups of eukaryotes (Hussey et al. 2002) . MAP65 was first purified from tobacco suspension cells as a 65 kDa MAP that binds to and bundles microtubules (Chang-Jie and Sonobe 1993) . Further studies then showed that many proteins from this family, such as NtMAP65-1b in tobacco, AtMAP65-1 and AtMAP65-6 in Arabidopsis, PRC1 in humans and Ase1 in yeast, exhibit this ability to bundle microtubules in vitro (Mollinari et al. 2002 , Schuyler et al. 2003 , Smertenko et al. 2004 , Wicker-Planquart et al. 2004 , Mao et al. 2005 . According to electron microscopic observation, carrot MAP65s and Arabidopsis MAP65-1 form 25-30 nm crossbridges between microtubules (Chan et al. 1999 , Smertenko et al. 2004 , Mao et al. 2005 . This is a relatively large gap to span. Recent work suggests that it can be bridged by homodimers (Smertenko et al. 2004) . However, it is not known how this kind of cross-bridge is formed. A useful model is provided by a-actinin, which cross-links actin filaments in muscle and non-muscle cells (Ott 1994) . The linker region of a-actinin is composed of four spectrin repeats and constitutes a rod domain. The crystal structure of this rod domain reveals that in order to cross-link actin filaments, a-actinin forms a twisted antiparallel dimer such that the N-terminus of the rod domain binds to the C-terminus of the rod domain (Ylanne et al. 2001) .
Nine members of the MAP65 protein family have been identified in Arabidopsis, which share an amino acid identity between 22 and 82% (Hussey et al. 2002) . One family member, AtMAP65-1, was found to decorate interphase microtubules. It is also found at the midzone of the anaphase spindle and the midline of the cytokinetic phragmoplast (Smertenko et al. 2004) . Such localizations suggest that AtMAP65-1 probably cross-links antiparallel microtubules in vivo. The function of bundling microtubules is therefore crucial for the parallel and antiparallel organization of microtubules in plant cells (Smertenko et al. 2004, Sasabe and Machida 2006) . However, another family member, AtMAP65-4, preferentially localizes to the spindle poles, which is not indicative of microtubule-bundling activity (Van Damme et al. 2004) . Therefore, although they share high amino acid identity, the proteins of the AtMAP65 family exhibit different microtubule-bundling properties.
According to their predicted secondary structure, all members of the MAP65 family probably have conserved multiple coiled-coil sequences in their N-terminal halves (Schuyler et al. 2003) . Detailed study is therefore needed to gain insight into the mechanism of MAP65 cross-bridge formation.
In the present study, we obtained a three-dimensional structure of AtMAP65-1 by the fold recognition method, indicating that AtMAP65-1 contains four coiled-coil domains and a disordered loop. We then expressed fulllength and truncated versions of AtMAP65-1 in bacteria to test how these molecules participate in spacing microtubules in the microtubule bundles. Our studies suggest that the cross-bridge consists of only one antiparallel homodimer of AtMAP65-1.
Results

Prediction of AtMAP65-1 structure
We used the Fugue (Shi et al. 2001) fold recognition method to identify proteins structurally related to AtMAP65-1. This resulted in the identification of a potential template, the rod domain of a-actinin (PDB entry: 1hci, Chain: A) (Ylanne et al. 2001) , which matches AtMAP65-1 from amino acid residue 1 to 494. Although the sequence identity between the two matched sequences is only 9%, the identified hit revealed a Fugue score of 5.12, implying a 95% confidence level (generally, Fugue scores !5.0 mean 55% false positives). Using the alignment generated by Fugue, the Swiss-Model server (http:// swissmodel.expasy.org//SWISS-MODEL.html) was used to derive the 3D model of AtMAP65-1 1-494. However, no confident template is currently available for the amino acid residues 495-587.
In a complementary analysis, the secondary structure of AtMAP65-1 was predicted using profsec . The results showed that AtMAP65-1 1-494 is mainly composed of a-helices, whereas AtMAP65-1 495-587 is predicted to be composed of irregular coils. Comparing secondary structure information in the same alignment position (Fig. 1A) , the predicted secondary structure from profsec is in good agreement with the secondary structure observed in the structure of 1hciA. Furthermore, results from two protein disorder predictors, DISPROT (Peng et al. 2006) and DISOPRED (Ward et al. 2004) , were consistent in suggesting that AtMAP65-1 495-587 is likely to be a disordered region representing a structurally flexible extended loop.
In summary, the current model represents with some confidence the three-dimensional (3D) shape of AtMAP65-1 1-494 in the rod domain. The 3D model shows AtMAP65-1 1-494 to be comprised of four spectrin repeats (R1, R2, R3 and R4) (Fig. 1B, C) . Each repeat is folded into coiled-coil triple helices. Due to an inserted long loop (residues 194-213) , R2 is the most divergent structurally. The rod domain in a-actinin forms an antiparallel homodimer that determines the distance between crosslinked actin filaments (Ylanne et al. 2001) . By analogy, the rod domain in AtMAP65-1 (AtMAP65-1 1-494) may also be capable of forming an antiparallel homodimer. The current 3D model of the analogous rod domain in AtMAP65-1 could therefore provide insight into its potential function. Taking the above-predicted 3D model as one monomer, the fold recognition technique was employed again to predict the 3D structure for another monomer by using the 1hci (Chain: B) as the structure template. A theoretical dimeric structure for AtMAP65-1 was therefore built on the assumption that the interaction mode of AtMAP65-1 dimer is similar to that of the antiparallel homodimer of the a-actinin rod domain (Fig. 1D) . The established dimeric structure may provide further insight into those residues located in the binding interface between two monomers. Calculations based on the predicted 3D model indicate the size of the rod domain to be approximately 25 nm ($14 nm for amino acid residues 1-339 and 11 nm for amino acid residues 340-494). An extended rod structure of these dimensions would be capable of spanning the observed 25-30 nm gap between microtubules (Smertenko et al. 2004 , Mao et al. 2005 ).
The rod domain of AtMAP65-1 is responsible for the formation of AtMAP65-1 cross-bridges Next, we performed biochemical experiments to verify the predicted model of AtMAP65-1, examining the ability of different regions of AtMAP65-1 to form cross-links.
In the a-actinin model, the N-terminus of the rod domain binds to the C-terminus of the rod domain and forms a dimer to connect adjacent F-actin filaments (Ylanne et al. 2001) . Considering the similarity between the 3D structures of AtMAP65-1 and a-actinin, AtMAP65-1 is in principle capable of forming a dimer in the same way as a-actinin does. Therefore, we tested if the C-terminus of the AtMAP65-1 rod domain could bind to the N-terminus of the rod domain to form the cross-bridge by connecting two antiparallel AtMAP65-1 polypeptides. According to the alignment of AtMAP65 amino acid sequences suggested by Smertenko (2004) , the rod domain of AtMAP65-1 (amino acid residues 1-494) was divided into the N-terminus (amino acid residues 1-339) and C-terminus (amino acid residues 340-494). Accordingly, the truncated proteins [as glutathione S-transferase 
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The AtMAP65-1 cross-bridge between microtubules is formed by one dimer (GST)-and His-tagged fusion proteins] were prepared for chemical cross-linking experiments. GST-AtMAP65-1 1-339 and His-AtMAP65-1 340-494 were co-incubated and cross-linked by the zero-length cross-linker EDC {[3-(dimethylamino) propyl] carbodiimide}. Samples were analyzed with SDS-PAGE ( Fig. 2A) , and probed with anti-GST and anti-polyhistidine antibodies, respectively (Fig. 2B) . GST-AtMAP65-1 1-339 was detected as a dimer ( Fig. 2A, lane 2 ; B, lane 2), which was consistent with the previous report (Smertenko et al. 2004) , indicating that GST fusion did not affect the binding effect of the GST-AtMAP65-1 1-339 fusion protein.
In the presence of GST-AtMAP65-1 1-339 alone, a band with high molecular mass was detected. This band was identified only by anti-GST, and not by anti-polyhistidine antibody (Fig. 2B , lanes 2, 3 and 8), indicating that GST-AtMAP65-1 1-339 could dimerize by itself. However, in the presence of both GSTAtMAP65-1 1-339 and His-AtMAP65-1 340-494, an additional band was detected ( Fig. 2A , lane 3, see arrow). This band was identified specifically by both anti-GST and anti-polyhistidine antibodies on Western blot (Fig. 2B , lanes 3 and 8). Compared with the GST protein cross-linked alone ( Fig. 2A, lane 7 ; B, lane 5), no interaction was detected between the GST protein and His-AtMAP65-1 340-494 ( Fig. 2A, lane 5 ; B, lanes 4 and 9). These results establish that the N-terminus of the AtMAP65-1 rod domain is capable of binding to the C-terminus of the rod domain.
The microtubule-binding domain locates to amino acids 340-587 of AtMAP65-1 cross-bridges Smertenko (2004) hypothesized that there are two microtubule-binding domains within the AtMAP65-1 region 340-587 and that this region might function in binding to the microtubule lattice. To verify this hypothesis, the microtubule-binding activity of AtMAP65-1 340-587 was investigated in vitro. His-tagged AtMAP65-1 340-587 fusion protein was prepared and incubated with rhodaminelabeled, taxol-stabilized microtubules. Confocal microscopy showed that pre-formed rhodamine-labeled, taxol-stabilized microtubules appear as single, unbundled elements (Fig. 3A) . However, addition of AtMAP65-1 340-587 converted these into large bundles (Fig. 3B ). This could be reversed by the addition of 200 mM NaCl to strip the microtubule-binding protein (Fig. 3C ). This result confirms that AtMAP65-1 340-587 has the ability to bind to and bundle microtubules in vitro.
Next, we used electron microscopy to examine the microtubule bundles induced by AtMAP65-1 340-587. Thin sections revealed that this fragment formed cross-bridges between microtubules of approximately 10-15 nm in length (Fig. 3D) . The size of these smaller cross-bridges was consistent with our prediction based on the amino acid sequence 340-494, which corresponds to the C-terminal rod region. Therefore, despite its truncation, AtMAP65-1 340-587 is still capable of cross-bridging microtubules. The fact that such diminished cross-bridges can form in the absence of the N-terminus suggests that the disordered loop within full-length AtMAP65-1 (amino acids 495-587) may not play a role in binding AtMAP65-1 into antiparallel homodimers. However, the correspondence of the observed cross-bridge size with the predicted molecular size suggests that the C-terminus of the rod domain could form part of the backbone of the AtMAP65-1 antiparallel homodimer. The microtubule-binding activity of AtMAP65-1 340-587 was then tested further by transiently expressing green fluorescent protein (GFP)-AtMAP65-1 340-587 in Arabidopsis pavement cells of Columbia gl1 background. Confocal microscopy observations indicated that GFP-AtMAP65-1 340-587 decorated microtubules (Fig. 4A) . To confirm that the labeling pattern of the fusion protein was related to microtubules, the transformed pavement cells were treated with the microtubule-disrupting drug, oryzalin, and the stabilizing drug, taxol, respectively. The results showed that the filamentous pattern of GFP-AtMAP65-1 340-587 was disrupted when cells were treated with oryzalin (Fig. 4B) . In contrast, more and thicker filaments of GFP-AtMAP65-1 340-587 were observed when cells were treated with taxol (Fig. 4C) . This shows that AtMAP65-1 340-587 is capable of binding to microtubules both in vitro and in vivo.
AtMAP65-1 495-587 plays a crucial role in binding to microtubules during cross-bridge formation
Because two separate microtubule-binding domains are suggested within the AtMAP65-1 340-587 region (Smertenko et al. 2004) , it is important to investigate whether one or both of them participate in microtubule binding within the cross-bridge. According to the predicted secondary structure, these two microtubule-binding domains correspond to the a-helices and irregular coils in this region. Two versions of truncation, AtMAP65-1 340-494 and AtMAP65-1 1-494, were chosen to distinguish the two microtubule-binding domains of the cross-bridges. The stability of the microtubule bundles induced by these truncated proteins was compared with that induced by full-length AtMAP65-1.
First, one microtubule-binding domain AtMAP65-1 495-587 in the region of AtMAP65-1 340-587 was removed and the C-terminus of the rod domain (amino acids 340-494) was used for analysis. The EDC cross-linking analysis (Fig. 2) showed that an additional band was detected on the gel after His-tagged AtMAP65-1 340-494 proteins were cross-linked ( Fig. 2A, lanes 4 and 6) . This band had a mol. wt of about 50 kDa and was identified using the anti-polyhistidine antibody (Fig. 2B, lane 7) , indicating that AtMAP65-1 340-494 formed dimers. However, this region is reported not to show microtubulebundling activity (Smertenko et al. 2004) . It is possible that the microtubule-binding site in this region is unavailable when AtMAP65-1 340-494 forms dimers. In this case, the other microtubule-binding site (AtMAP65-1 495-587) may be responsible for binding the AtMAP65-1 340-587 dimer to microtubules.
Next, we investigated the other microtubule-binding domain of AtMAP65-1 340-494. For this, we used 
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The AtMAP65-1 cross-bridge between microtubules is formed by one dimer AtMAP65-1 1-494, which contains only the single 340-494 microtubule-binding domain. Confocal microscopy showed that microtubule bundles formed in the presence of His-tagged AtMAP65-1 1-494 (Fig. 5C ). According to our protein structure analysis, AtMAP65-1 1-494 could be dimerized in the same way as the full-length AtMAP65-1. This indicates that the microtubule-binding domain of AtMAP65-1 340-494 is available within the larger 1-494 fragment for bundling microtubules. Having determined that it is possible to obtain two kinds of microtubule bundles induced by different microtubule-binding domains, we tried to distinguish between them using low temperature treatment and compared their properties with full-length AtMAP65-1.
Microtubules were assembled in a solution of 20 mM rhodamine-labeled tubulin in the presence or absence of 5 mM full-length AtMAP65-1, AtMAP65-1 340-587 or AtMAP65-1 1-494 at 358C for 30 min, and then treated immediately at 108C for 30 min. Samples were fixed before and after low-temperature treatment for further observation. Before low-temperature treatment, microtubules formed large bundles in the presence of AtMAP65-1 340-587, AtMAP65-1 1-494 and full-length AtMAP65-1 (Fig. 5B, C, D) . After low-temperature treatment at 108C, microtubules persisted in the presence of AtMAP65-1 340-587 and full-length AtMAP65-1 (Fig. 5F, H) , but disappeared in the presence of AtMAP65-1 1-494 or tubulin alone (Fig. 5G, E) . This indicates that the stabilizing effect of full-length AtMAP65-1 can be reproduced by the 340-587 fragment but not by the 1-494 fragment. We therefore suggest that the microtubule-binding domain in AtMAP65-1 495-587, but not that in AtMAP65-1 340-494, allows dimeric AtMAP65-1 to bind to microtubules during cross-bridge formation.
Discussion
In recent years, bioinformatic analysis has been increasingly employed for investigating protein structure and the functions of various protein regions. For example, using bioinformatic analysis, AtMAP70-1 was found to contain four coiled-coil domains and a non-regular secondary structure (NORS) region between amino acid residues 442 and 519 . Here, we present an analysis of the secondary structure of AtMAP65-1, providing a platform for investigating the organization of cross-bridges formed by AtMAP65-1. A suggested model for AtMAP65-1 cross-bridges is presented in Fig. 6 . In the model, the sequence of AtMAP65-1 from amino acids 1 to 494 mainly contains a-helices and constitutes the backbone of the cross-bridge.
Our predicted secondary structure of AtMAP65-1 shows strong similarities to the rod domain of a-actinin. a-Actinin is known to bundle actin filaments by the N-terminus of the rod domain binding to the C-terminus of the rod domain (Ylanne et al. 2001) . Our biochemical data also show that the N-terminus of the rod domain of AtMAP65-1 does bind to the C-terminus of the rod domain AtMAP65-1 cross-bridge between microtubules is formed by one dimerto connect the two antiparallel AtMAP65-1 proteins. The 151-339 amino acid sequence of AtMAP65-1 showed the greatest similarity to tobacco NtMAP65-1 and was suggested to be involved in the dimerization of AtMAP65-1 (Smertenko et al. 2004 ). However, we did not detect any interaction between the C-terminus of the rod domain with either AtMAP65-1 1-150 or AtMAP65-1 151-339 alone by EDC cross-linking analysis (data not shown). For this reason, in our model of the AtMAP65-1 cross-bridge, we suggest that it is the whole N-terminus of the rod domain that binds to the C-terminus of the rod domain in order to connect the two antiparallel AtMAP65-1 proteins.
In vitro analysis has suggested that the microtubule-binding domain of AtMAP65-1 locates to the amino acid region 340-587 (Smertenko et al. 2004 , Li et al. 2007 . Here, by transient expression in Arabidopsis pavement cells, we confirm that this region exhibits its microtubule-binding activity in vivo.
Within the nine-member Arabidopsis MAP65 family, the 340-494 region of the microtubule-binding domain is highly conserved (Smertenko et al. 2004 ) and shows a high similarity to its homologs, mammalian PRC1 and yeast Ase1p (Schuyler et al. 2003) . This suggests that the ability of AtMAP65 proteins to bind to microtubules is likely to depend on this region. However, our experimental results suggest that AtMAP65-1 495-587, not AtMAP65-1 340-494, is the most important microtubule-binding region for cross-bridge formation. Hence, in our cross-bridge model, we suggest that AtMAP65-1 495-587, as a flexible extended loop, plays the crucial role in binding, bundling and stabilizing microtubules. The same secondary structure has also been found in other families of MAPs, such as AtMAP70. There, the NORS region of AtMAP70-1 represents a structurally flexible extended loop that truncation indicates may play an important functional role (Korolev et al. 2005) .
There are two elements in the cross-bridging of microtubules by MAP65: first, the 25-30 nm intermicrotubule cross-bridges; and, secondly, the spacing of these bridges along the microtubule lattice. Examination of microtubules bundled by carrot MAP65 proteins shows that the cross-bridges are not randomly arranged along the microtubule but correspond to a 12-dimer super lattice arrangement and/or to a 34 nm axial repeat (Chan et al. 1999) . However, how this regular spacing along microtubules is formed is still unknown. According to our data and model, when two antiparallel AtMAP65-1 proteins form a dimer, the whole rod domain participates in this, and the disordered loops extend from the ends of the dimer. We detected the dimerization of this disordered loop, and our experimental results show that AtMAP65-1 495-587 can form dimers (Supplementary Fig. S1 ). We therefore hypothesize that this extended disordered loop not only is responsible for binding to microtubules, but might also take part in determining the axial spacing between two adjacent bridges by means of their dimerization. We suggest that AtMAP65-1 495-587 is important for cross-bridge formation, and this is consistent with what is known about this sequence in other proteins. For example, AtMAP65-1 495-587 shares the highest identity with AtMAP65-2 (58%) and . Not all members of the AtMAP65 family bundle and cross-bridge microtubules, but AtMAP65-2 and -6 do (Mao et al. 2005 , our unpublished data), supporting a more general contribution of the AtMAP65-1 495-587 region to bundling activity within the AtMAP65 family.
Materials and Methods
Plasmids and constructs
The full-length and truncated versions of AtMAP65-1 were obtained as previously described (Li et al. 2007 ). The GST-or His-tagged fusion proteins were expressed and purified according to the manufacturer's protocols.
Cross-linking assay
After centrifugation at 200,00 Â g for 20 min at 48C, 20 mM GST-AtMAP65-1 1-339, His-AtMAP65-1 340-494, HisAtMAP65-1 495-587 or GST protein were placed alone or mixed in PEM buffer (1 mM MgCl 2 , 1 mM EGTA and 100 mM PIPES-KOH, pH 6.9) for 30 min on ice. Zero-length cross-linker EDC (2 mM) (Pierce Biotechnology, Rockford, IL, USA) was then added, and the solution was kept at room temperature for 30 min. 
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The reaction was quenched by adding the same volume of 2Â SDS sample buffer. Samples were subjected to SDS-PAGE and probed with anti-polyhistidine (Sigma) or anti-GST antibodies (Sigma) for Western blotting analysis.
Microtubule observation Porcine brain tubulin was purified according to Castoldia and Popov (2003) . The purified tubulin was labeled with 5-(and 6-)carboxytetramethylrhodamine succinimidyl ester (NHS)-rhodamine as reported (Hyman 1991) .
In the NaCl treatment, 20 mM rhodamine-labeled tubulin was assembled alone at 358C for 30 min. Then 10 mM taxol was added to stabilize microtubules. Rhodamine-labeled, taxol-stabilized microtubules were incubated with 1 mM AtMAP65-1 340-587 in PEM buffer at room temperature for 30 min. NaCl (200 mM) was added and the reaction was terminated by addition of 1% (v/v) glutaraldehyde after incubation for 10 min.
The samples were examined with a Zeiss LSM 510 META confocal microscope (Zeiss, Jena, Germany). Objectives of Zeiss 100Â (Plan-APOCHROMAT, NA 1.4) and 63Â (Plan-APOCHROMAT, NA 1.4) were used for the observations.
Electron microscopy was carried out as described in Mao (2005) , using a Hitachi 7500 electron microscope (Hitachi, Tokyo).
GFP-AtMAP65-1 340-587 transformation and observation
For transient expression of the GFP fusion protein in living cells, the truncated version of AtMAP65-1 340-587 was amplified by PCR and then was subcloned into the vector pBI221 containing a cauliflower mosaic virus (CaMV) 35S promoter. The pavement cells of Arabidopsis Columbia gl1 background were bombarded with particles coated with this plasmid, and subsequently cultured at 258C for 2 h in the dark. To confirm AtMAP65-1 340-587 decorated microtubules, pavement cells transformed with GFP-AtMAP65-1 340-587 were treated with 20 mM of the microtubule-disrupting drug, oryzalin (3,5-dinitro-N4, N4-dipropylsulfanilamide, Ps-410) and the microtubule-stabilizing drug, taxol (Paclitaxel, Sigma), at room temperature for 30 min or 2 h, respectively. The samples were examined with a Zeiss LSM 510 META confocal microscope (Zeiss, Jena, Germany).
Low-temperature treatment
Rhodamine-labelled tubulin (20 mM) was polymerized in the PEM buffer containing 1 mM GTP with or without 5 mM AtMAP65-1 or the truncations of AtMAP65-1 at 358C for 30 min. The cold treatment was performed immediately at 108C for 30 min after incubation. Then 1% (v/v) glutaraldehyde was added to quench the reaction. The samples were observed by confocal microscopy.
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